Invitae Corporation has entered into definitive agreement to acquire privately held Good Start Genetics, a molecular diagnostics company focused on preimplantation and carrier screening for inherited disorders, and a definitive agreement to acquire CombiMatrix, a company which specialises in prenatal diagnostics, miscarriage analysis and pediatric developmental disorders. 

CLICK TO ENLARGE / Illustration: Invitae Corporation.

“This is a transformative moment for Invitae, for our industry, and —importantly — for patients. By acquiring Good Start and CombiMatrix, Invitae intends to create the industry’s first comprehensive genetic information platform providing high-quality, affordable genetic information coupled with world-class clinical expertise to inform healthcare decisions throughout every stage of an individual’s life,” said Sean George, chief executive officer of Invitae. “We believe the strength of our existing platform, strategic acquisitions like these and our network of partners will fuel continued growth and further establish Invitae as a leading genetic information service provider.”

Good Start’s suite of offerings includes carrier screening and preimplantation embryo testing, which provides women, their partners and their clinicians with insightful and actionable information to promote successful pregnancies and help build healthy families.

“We are excited to bring our world-class, proprietary approach to genetic testing for women who are pregnant or planning to become pregnant to the Invitae platform,” said Jeffrey Luber, president and chief executive officer of Good Start. “Our companies share a belief in the power of genetic information to transform people’s lives and a common commitment to making that information affordable and available to all. Today, we are thrilled to bring the momentum we’ve built in IVF to Invitae. Together we will enhance our combined offerings in this important category and bring that comprehensive solution to our customers for the benefit of growing audiences everywhere.”

Good Start was the first to bring next-generation sequencing to reproductive health and, with its three primary product lines, has processed 1.7 million tests since its commercial launch in 2012.

The acquisition of CombiMatrix will complement Invitae and Good Start’s genetic information services to establish a category-leading menu with the breadth and depth needed to provide comprehensive support for women, their partners and clinicians to use genetic information when considering their reproductive health options.

“We are excited to be joining forces with Invitae. This combination of CombiMatrix, a recognized leader in genetic testing for Miscarriage Analysis, with one of the fastest growing genetic information companies in Invitae provides a tremendous opportunity to accelerate the growth of both companies. The information that we will be able to provide as a combined entity will enable clinicians to help guide women through some of the most important health decisions they make along the continuum of care in family planning,” says Mark McDonough, president and chief executive officer of CombiMatrix. “We are eager to combine our complementary product portfolio, expertise and relationships to create the market leader in family health genetics.”